[go: up one dir, main page]

AU2002230609A1 - Aerodynamically light vaccine for active pulmonary immunization - Google Patents

Aerodynamically light vaccine for active pulmonary immunization

Info

Publication number
AU2002230609A1
AU2002230609A1 AU2002230609A AU3060902A AU2002230609A1 AU 2002230609 A1 AU2002230609 A1 AU 2002230609A1 AU 2002230609 A AU2002230609 A AU 2002230609A AU 3060902 A AU3060902 A AU 3060902A AU 2002230609 A1 AU2002230609 A1 AU 2002230609A1
Authority
AU
Australia
Prior art keywords
aerodynamically light
active pulmonary
vaccine
immunization
pulmonary immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230609A
Inventor
Bradley S. Bender
Parker Small
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Publication of AU2002230609A1 publication Critical patent/AU2002230609A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU2002230609A 2000-12-01 2001-12-03 Aerodynamically light vaccine for active pulmonary immunization Abandoned AU2002230609A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25079500P 2000-12-01 2000-12-01
US60/250,795 2000-12-01
PCT/US2001/046549 WO2002043705A2 (en) 2000-12-01 2001-12-03 Aerodynamically light vaccine for active pulmonary immunization

Publications (1)

Publication Number Publication Date
AU2002230609A1 true AU2002230609A1 (en) 2002-06-11

Family

ID=22949174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230609A Abandoned AU2002230609A1 (en) 2000-12-01 2001-12-03 Aerodynamically light vaccine for active pulmonary immunization

Country Status (3)

Country Link
US (1) US20020159954A1 (en)
AU (1) AU2002230609A1 (en)
WO (1) WO2002043705A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
AU2002346424A1 (en) 2001-11-19 2003-06-10 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
JP3707780B2 (en) * 2002-06-24 2005-10-19 東京応化工業株式会社 Coating forming agent for pattern miniaturization and method for forming fine pattern using the same
GB0300427D0 (en) * 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition
US20050265928A1 (en) * 2004-05-07 2005-12-01 President And Fellows Of Harvard College Massachusetts Pulmonary malarial vaccine
GB0416694D0 (en) * 2004-07-27 2004-09-01 Univ Strathclyde Process for preparing microcrystals
WO2006055950A1 (en) * 2004-11-18 2006-05-26 Nektar Therapeutics Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents
GB0707938D0 (en) * 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
GB0724498D0 (en) * 2007-12-15 2008-01-30 Univ Strathclyde Slow release compositions
US20150297706A1 (en) * 2014-04-18 2015-10-22 Auburn University Particulate Vaccine Formulations for Inducing Innate and Adaptive Immunity
US10293044B2 (en) 2014-04-18 2019-05-21 Auburn University Particulate formulations for improving feed conversion rate in a subject
CN110368488B (en) * 2019-07-23 2021-08-31 中国农业大学 Preparation and application of recombinant argF protein nanoparticles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798836A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Inhalable live virus veterinary vaccine
GB1055465A (en) * 1962-09-27 1967-01-18 Vantorex Ltd Allergenic aerosol compositions
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO2000000215A1 (en) * 1998-06-29 2000-01-06 Inhale Therapeutic Systems, Inc. Particulate delivery systems and methods of use

Also Published As

Publication number Publication date
US20020159954A1 (en) 2002-10-31
WO2002043705A3 (en) 2003-02-20
WO2002043705A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002236159A1 (en) Immunogenic complex
AU2001270755A1 (en) Optical structure
AU2002239532A1 (en) Light projector
AU2002353378A1 (en) Vaccine for periodontal disease
AU2001271389A1 (en) Optical system
AU2001280908A1 (en) Rotavirus vaccine formulations
AU2001258279A1 (en) Adjuvant for vaccines
AU2002254558A1 (en) Novel vaccine
AU2001295926A1 (en) Process for producign optically active ethyl
AU2002230609A1 (en) Aerodynamically light vaccine for active pulmonary immunization
AUPQ520800A0 (en) Prime-boost vaccination strategy
AU2292600A (en) Varicella-zoster virus vaccines
AU1738201A (en) Adjuvants for nucleic acid vaccines
AU2001278323A1 (en) Modified sialic acid vaccines
AU6158700A (en) Vaccine
AUPR160400A0 (en) Plant virus promoter
AU2001247453A1 (en) Genetically stable cholera vaccines
AU2002249823A1 (en) Acne vaccine
AU2002254161A1 (en) M cell directed vaccines
AU2002236065A1 (en) Papillomavirus vaccines
AU2002327959A1 (en) Adjuvants for nucleic acid vaccines
AU2001267541A1 (en) Vaccine composition
AU4957800A (en) Vaccine against isa virus
AU5811600A (en) Vaccine
AU4606000A (en) Vaccine for newcastle disease virus